Book an appointment with us, or search the directory to find the right lawyer for you directly through the app.
Find out moreReal estate, construction, and hospitality are at the forefront of transformation across the Middle East – reshaping cities, driving investment, and demanding increasingly sophisticated legal frameworks.
In the June edition of Law Update, we take a closer look at the legal shifts influencing the sector – from Dubai’s new Real Estate Investment Funds Law and major reforms in Qatar, to Bahrain’s push toward digitalisation in property and timeshare regulation. We also explore practical issues around strata, zoning, joint ventures, and hotel management agreements that are critical to navigating today’s market.
As the landscape becomes more complex, understanding the legal dynamics behind these developments is key to making informed, strategic decisions.
2025 is set to be a game-changer for the MENA region, with legal and regulatory shifts from 2024 continuing to reshape its economic landscape. Saudi Arabia, the UAE, Egypt, Iraq, Qatar, and Bahrain are all implementing groundbreaking reforms in sustainable financing, investment laws, labor regulations, and dispute resolution. As the region positions itself for deeper global integration, businesses must adapt to a rapidly evolving legal environment.
Our Eyes on 2025 publication provides essential insights and practical guidance on the key legal updates shaping the year ahead—equipping you with the knowledge to stay ahead in this dynamic market.
The UAE has introduced Federal Law No. 38 of 2024, replacing Federal Law No. 8 of 2019 concerning medical products, pharmacists, and pharmaceutical establishments. The new legislation came into force on the 2nd of January, 2025 and implements significant reforms to the regulation of medical products and pharmaceutical practices, with a focus on enhanced safety, stricter compliance, and modernised regulatory frameworks.
Key Provisions:
Implications for Stakeholders:
Comparative Analysis: Federal Law No. 8 of 2019 vs. Federal Law No. 38 of 2024 | ||||||||||||||||||||||||||||||||
|
Conclusion:
Federal Law No. 38 of 2024 introduces a modernised regulatory landscape for the UAE’s pharmaceutical sector, enhancing consumer protection, regulatory efficiency, and innovation incentives. Stakeholders should review internal compliance policies to align with the new provisions and engage proactively with the EDE to ensure continued market access and regulatory adherence.
For further information or specific legal guidance, please feel free to contact our healthcare practice group team members Andrea Tithecott (A.Tithecott@tamimi.com) or Christina Sochacki (C.Sochacki@tamimi.com)
To learn more about our services and get the latest legal insights from across the Middle East and North Africa region, click on the link below.